136 related articles for article (PubMed ID: 30686137)
1. Increased physical activity post-exacerbation is associated with decreased systemic inflammation in cystic fibrosis - An observational study.
Burton K; Morris NR; Reid D; Smith D; Kuys S
Physiother Theory Pract; 2020 Dec; 36(12):1457-1465. PubMed ID: 30686137
[No Abstract] [Full Text] [Related]
2. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis.
Paats MS; Bergen IM; Bakker M; Hoek RA; Nietzman-Lammering KJ; Hoogsteden HC; Hendriks RW; van der Eerden MM
J Cyst Fibros; 2013 Dec; 12(6):623-9. PubMed ID: 23751406
[TBL] [Abstract][Full Text] [Related]
4. Physical activity participation by adults with cystic fibrosis: An observational study.
Cox NS; Alison JA; Button BM; Wilson JW; Morton JM; Holland AE
Respirology; 2016 Apr; 21(3):511-8. PubMed ID: 26715596
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
6. Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
Laguna TA; Wagner BD; Luckey HK; Mann SA; Sagel SD; Regelmann W; Accurso FJ
Chest; 2009 Dec; 136(6):1561-1568. PubMed ID: 19567495
[TBL] [Abstract][Full Text] [Related]
7. Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.
Sagel SD; Thompson V; Chmiel JF; Montgomery GS; Nasr SZ; Perkett E; Saavedra MT; Slovis B; Anthony MM; Emmett P; Heltshe SL
Ann Am Thorac Soc; 2015 May; 12(5):708-17. PubMed ID: 25714657
[TBL] [Abstract][Full Text] [Related]
8. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
Kim JS; Okamoto K; Rubin BK
Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
[TBL] [Abstract][Full Text] [Related]
10. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.
Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H
Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432
[TBL] [Abstract][Full Text] [Related]
11. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM
PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205
[TBL] [Abstract][Full Text] [Related]
12. Improvement in body composition following a supervised exercise-training program of adult patients with cystic fibrosis.
Prévotat A; Godin J; Bernard H; Perez T; Le Rouzic O; Wallaert B
Respir Med Res; 2019 May; 75():5-9. PubMed ID: 31235455
[TBL] [Abstract][Full Text] [Related]
13. Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.
Laguna TA; Wagner BD; Starcher B; Luckey Tarro HK; Mann SA; Sagel SD; Accurso FJ
Pediatr Pulmonol; 2012 Sep; 47(9):856-63. PubMed ID: 22431382
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis.
Wolter JM; Rodwell RL; Bowler SD; McCormack JG
Clin Diagn Lab Immunol; 1999 Mar; 6(2):260-5. PubMed ID: 10066664
[TBL] [Abstract][Full Text] [Related]
15. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
16. Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis.
Piva TC; Luft C; Antunes KH; Marostica PJC; Pinto LA; Donadio MVF
Respir Med; 2020 Oct; 172():106144. PubMed ID: 32937222
[TBL] [Abstract][Full Text] [Related]
17. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic monitoring of patients with cystic fibrosis: value of different laboratory findings].
Pevnitskiĭ LA; Pukhal'skiĭ AL; Kapranov NI; Kalashnikova EA; Shmarina GV; Pukhal'skaia DA; Kokarovtseva SN; Kashirskaia NIu; Shabalova LA
Vestn Ross Akad Med Nauk; 2000; (5):40-6. PubMed ID: 10881662
[TBL] [Abstract][Full Text] [Related]
19. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.
Horsley AR; Davies JC; Gray RD; Macleod KA; Donovan J; Aziz ZA; Bell NJ; Rainer M; Mt-Isa S; Voase N; Dewar MH; Saunders C; Gibson JS; Parra-Leiton J; Larsen MD; Jeswiet S; Soussi S; Bakar Y; Meister MG; Tyler P; Doherty A; Hansell DM; Ashby D; Hyde SC; Gill DR; Greening AP; Porteous DJ; Innes JA; Boyd AC; Griesenbach U; Cunningham S; Alton EW
Thorax; 2013 Jun; 68(6):532-9. PubMed ID: 23396354
[TBL] [Abstract][Full Text] [Related]
20. Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function.
Ma JT; Tang C; Kang L; Voynow JA; Rubin BK
Chest; 2018 Aug; 154(2):370-377. PubMed ID: 29559310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
